Bausch Health Companies | VRX - Gross Profit On Sales

Stock Price
8.03
Daily Change
0.19 2.42%
Monthly
-26.67%
Yearly
-13.00%
Q1 Forecast
7.62

Bausch Health Companies reported $1.93B in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Amgen USD 6.48B 307M Sep/2025
ANI Pharmaceuticals USD 111.79M 1.68M Sep/2025
Aurora Cannabis CAD 32.29M 4.34M Sep/2025
Bausch Health Companies USD 1.93B 165M Sep/2025
Biogen USD 1.65B 34.6M Dec/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Canopy Growth CAD 21.9M 3.86M Sep/2025
Corcept Therapeutics USD 203.04M 12.04M Sep/2025
Danaher USD 3.97B 443M Dec/2025
Drreddys Laboratories INR 46.81B 10.24B Dec/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Gilead Sciences USD 5.58B 453M Jun/2025
Novo Nordisk DKK 64.01B 1.19B Jun/2025
Pacira USD 130.92M 5M Sep/2025
Perrigo USD 377.1M 14.2M Sep/2025
Prestige Brands USD 157.37M 5.79M Dec/2025
Supernus Pharmaceuticals USD 148.81M 21.01M Sep/2025
Vertex Pharmaceuticals USD 2.66B 104.4M Sep/2025
Zoetis USD 1.72B 96M Sep/2025